Subpart D—Provisional Health Effects Guidelines

1. CFR
2. ›
3. Title 40
4. ›
5. Chapter I
6. ›
7. Part 795
8. ›
9. Subpart D

Sections

Section numbering in the official eCFR can be non-consecutive. Omitted section numbers are not treated here as reserved unless the source explicitly labels them that way.

• 795.225
  § 795.225 Dermal pharmacokinetics of DGBE and DGBA.
• 795.228
  § 795.228 Oral/dermal pharmacokinetics.
• 795.231
  § 795.231 Pharmacokinetics of isopropanal.
• 795.232
  § 795.232 Inhalation and dermal pharmacokinetics of commercial hexane.
• 795.250
  § 795.250 Developmental neurotoxicity screen.